Literature DB >> 17141529

Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing.

S Behnke1, K L Double, S Duma, G A Broe, V Guenther, G Becker, G M Halliday.   

Abstract

Transcranial sonography reveals an increase in echogenicity in the substantia nigra of patients with idiopathic Parkinson's disease. Marked hyperechogenicity has also been described in 9% of the healthy population and is associated with subtle clinical or functional neuroimaging findings suggestive of changes in nigrostriatal function. It has therefore been hypothesised that a hyperechogenic substantia nigra represents an early stage of nigral degeneration or a predisposition for Parkinson's disease. In the present study, we correlated sonographic findings with motor and cognitive deficits in a group of healthy, very elderly subjects. Marked and moderately increased substantia nigra echogenicity was present in 25% and 21% of our healthy, very elderly subjects, respectively, and correlated strongly with the presence of extrapyramidal symptoms in the absence of cognitive deficits. The high incidence of substantia nigra hyperechogenicity measured in our very elderly subjects compared with previous TCS studies suggests that the prevalence of this feature increases with age and is consistent with the higher prevalence of Parkinson's disease in advanced age, as well as the increased frequency of extrapyramidal symptoms. Our results indicate that this simple technique can be used to identify and quantify brain changes associated with subtle motor dysfunction in the very elderly.

Entities:  

Mesh:

Year:  2006        PMID: 17141529     DOI: 10.1016/j.neuroimage.2006.10.010

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  16 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Basal ganglia hyperechogenicity does not distinguish between patients with primary dystonia and healthy individuals.

Authors:  Johann Hagenah; Inke R König; Charlotte Kötter; Günter Seidel; Christine Klein; Norbert Brüggemann
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

3.  Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population.

Authors:  Inga Liepelt; Angela Wendt; Katherine J Schweitzer; Bjoern Wolf; Jana Godau; Alexandra Gaenslen; Theresa Bruessel; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2008-03-27       Impact factor: 3.575

4.  Substantia nigra hyperechogenicity with LRRK2 G2019S mutations.

Authors:  Norbert Brüggemann; Johann Hagenah; Kaili Stanley; Christine Klein; Cuiling Wang; Deborah Raymond; Laurie Ozelius; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2011-02-10       Impact factor: 10.338

5.  Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson's Disease Rating Scale in the elderly population.

Authors:  Inga Liepelt-Scarfone; Stefanie Lerche; Stefanie Behnke; Jana Godau; Alexandra Gaenslen; Christoph Pausch; Klaus Fassbender; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Daniela Berg
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

Review 6.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 7.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

Review 8.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

9.  Relation of risk factors and putative premotor markers for Parkinson's disease.

Authors:  I Liepelt-Scarfone; S Behnke; J Godau; K J Schweitzer; B Wolf; A Gaenslen; D Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-06       Impact factor: 3.575

Review 10.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.